AnalystsMaxwell SkorMaxwell Skor's Stock Forecasts
AnalystsMaxwell Skor
Sectors:
Industries:
Analyst Ranking
Top 33%
#1701 out of 5177 analysts
Average Return
+42.62%
Win Rate
71%5 out of 7
Risk vs Reward
Poor
Good
Maxwell Skor's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Invivyd IncIVVD | +225.52% | $0.77 | $2.50 | 2024-11-19 - 2025-11-19 | Strong Buy |
Cidara Therapeutics IncCDTX | +117.00% | $102.02 | $221.38 | 2025-10-15 - 2026-01-06 | Strong Buy |
Sana Biotechnology IncSANA | +43.57% | $3.19 | $4.58 | 2025-07-02 - 2026-01-16 | Strong Buy |
Ascendis Pharma AASND | +18.17% | $174.18 | $205.83 | 2025-07-02 - 2026-01-16 | Strong Buy |
Monopar TherapeuticsMNPR | +11.11% | $63.00 | $70.00 | 2026-01-08 - 2026-01-16 | Strong Buy |
Maxwell Skor Analyst Color
Get additional color on Maxwell Skor's coverage of popular stocks
Maxwell Skor's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Monopar TherapeuticsMNPR | 1 | Strong Buy | $115.00 | +64.29% | Initiates Coverage On | 8 days ago |
Cidara Therapeutics IncCDTX | 1 | Strong Buy | $190.00 | -14.17% | Initiates Coverage On | 3 months ago |
Insmed IncINSM | 1 | Hold | $144.00 | -10.79% | Maintains | 5 months ago |
Ascendis Pharma AASND | 1 | Strong Buy | $250.00 | +21.46% | Assumes | 6 months ago |
Sana Biotechnology IncSANA | 1 | Strong Buy | $12.00 | +162.01% | Assumes | 6 months ago |
Tscan Therapeutics IncTCRX | 1 | Strong Buy | $10.00 | +784.96% | Assumes | 10 months ago |
Invivyd IncIVVD | 2 | Strong Buy | $3.55 | N/A | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.